1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
HOUSE_OVERSIGHT_024817_sub_001 - HOUSE_OVERSIGHT_024916
stribute CBD products. 86 COWEN.COM HOUSE_OVERSIGHT_024902 COWEN COLLABORATIVE INSIGHTS February 25, 2019 Additional Applications / Implications (Nadeau & Osborne) 2 Epilepsy & Psychiatric Conditions (Nadeau) For companies willing to invest in research and manufacturing, the development of FDA- approved cann
No connected entities